Drugs for rare diseases – Newfoundland and Labrador agreement
The Governments of Canada and Newfoundland and Labrador have signed a $22 million agreement under the National Strategy for Drugs for Rare Diseases to improve access to treatments, enhance screening, and support early diagnosis for individuals with rare diseases.